INGR
NYSE · Consumer Defensive · Packaged Foods · US
Research · Sep 3, 2026
INGR Ingredion Incorporated Thesis 2026: Texture Healthful Solutions Drive Specialty Ingredient Margin Mix Shift
Ingredion Incorporated (NYSE: INGR) FY2026 thesis centers on continued Texture & Healthful Solutions Specialty Ingredient pipeline (~$2.60-2.90B revenue) + Food & Industrial Ingredients North America + LATAM Core pipeline (~$4.60-5.30B revenue) under continued President + CEO James Zallie since 2018 (~7-year tenure as Ingredion CEO; selected post-2018 succession from Ilene Gordon retirement after ~9-year tenure 2009-2018; selected primary internal promotion + selected primary architect of post-2018 strategic reset toward Texture & Healthful Solutions specialty ingredient mix shift + post-2024-2025 portfolio optimization + cost discipline). FY2025 revenue ~$7.30-7.80B (+0-5% YoY) with adj. EPS ~$11.00-12.50 reflecting continued ~$1.1-1.3B aggregate adj. EBITDA. INGR operates 3 primary segments: Texture & Healthful Solutions ~35-38% revenue ($2.60-2.90B; specialty texturizers + plant-based protein + sugar reduction + sweetener nutrition; ~highest-margin segment ~16-20% operating margin) + Food & Industrial Ingredients North America ~43-46% revenue ($3.20-3.60B; corn/grain-based starches + sweeteners — HFCS + glucose syrup + dextrose + maltodextrin + industrial starches; ~8-12% operating margin) + Food & Industrial Ingredients LATAM ~18-22% revenue ($1.40-1.70B; Brazil + Mexico + Andean corn/grain-based starches + sweeteners; ~10-15% operating margin) with geographic mix North America ~55-60% + Latin America ~20-25% + EMEA + Asia Pacific ~15-25%. Texture & Healthful Solutions Specialty Ingredient pipeline (~$2.60-2.90B revenue + ~35-38% revenue mix + ~highest-margin segment ~16-20% operating margin): selected primary specialty texturizers (modified + functional starches + hydrocolloids + clean-label + non-GMO + organic texturizers) + plant-based protein (pea protein + post-2020 PureCircle stevia/sugar reduction acquisition) + sugar reduction (stevia + allulose) + sweetener nutrition + fiber + prebiotics + post-2024-2025 specialty ingredient mix shift toward Texture & Healthful Solutions (~targeting ~40%+ aggregate specialty revenue mix by ~2027-2028). Food & Industrial Ingredients North America + LATAM Core pipeline (~$4.60-5.30B revenue + ~62-65% revenue mix): selected primary Food & Industrial Ingredients North America (corn/grain-based starches + sweeteners — high fructose corn syrup (HFCS) + glucose syrup + dextrose + maltodextrin + industrial starches — paper + corrugating + textile + ~8-12% FII-NA operating margin) + Food & Industrial Ingredients LATAM (Brazil + Mexico + Andean corn/grain-based starches + sweeteners + ~10-15% FII-LATAM operating margin) + ~corn cost net (gross profit vs corn cost spread) + post-2024-2025 Food & Industrial Ingredients pricing + corn cost net margin dynamics. Capital position + balance sheet: ~$3.10 aggregate annual dividend (~25-30% payout; ~2.0-3.0% yield; selected ~15+ year aggregate consecutive dividend increase track record) + ~$100-500M aggregate FY2025 buybacks + aggregate capital return ~$300-700M FY2025 + net leverage ~1.5-2.5x Net Debt/EBITDA + investment-grade BBB/Baa2 credit rating + ~64-66M aggregate diluted shares. FY2026 base case ~$7.40-7.95B aggregate revenue + ~$11.50-13.00 adj. EPS + ~$310-720M aggregate capital return; bull case Texture & Healthful Solutions Specialty Ingredient pipeline acceleration (specialty texturizers + plant-based protein + sugar reduction + clean-label demand + ~16-22% operating margin + ~targeting ~40%+ specialty revenue mix by ~2027-2028 + Food & Beverage customer reformulation acceleration) + Food & Industrial Ingredients North America + LATAM Core pipeline acceleration (corn cost net margin expansion + pricing pass-through + Brazil + Mexico + Andean growth + cost discipline) drives ~$7.70-8.30B aggregate revenue + ~$13.00-14.50 EPS; bear case Cargill + ADM + Tate & Lyle + Kerry Group + IFF + Givaudan + Roquette + Grain Processing + Tereos competitive intensification + Food & Beverage customer reformulation cycle considerations + clean-label demand cycle considerations + plant-based protein demand cycle considerations + corn cost cycle considerations (corn cost net margin sensitivity) + HFCS demand cycle considerations (sugar substitution + consumer sweetener preferences) + industrial starch demand cycle considerations (paper + corrugating + textile) + Brazil + Mexico + Andean economic + currency cycle considerations + ethanol economics considerations + specialty ingredient pricing considerations + post-2018 James Zallie CEO succession planning considerations (~7-year tenure) drives ~$7.10-7.40B revenue + ~$10.00-11.50 EPS.
Research · Aug 25, 2026
Manufacturing Ties Oil Cost Recovery to Contract Length
Cabot, LSI Industries and Flowers Foods all cited the same 2026 crude spike on August calls, but recovery ranged from pricing ahead of cost to no recovery at all.
Research · Jun 9, 2026
INGR Stock: Ingredion £2.7B Tate & Lyle Acquisition Explained
Ingredion is in advanced talks to acquire Tate & Lyle for £2.7B in a transformative food ingredients deal. What it means for INGR.